ParkinsonFranceV1, UK, Analysis, indexHead, KwdEn.i

Index : Keywords

Liste des classifications (clusters par fréquence et par distance de cosinus):

Les termes de plus forte occurence

149	Parkinson disease
98	Humans
82	Nervous system diseases
78	Human
67	Male
60	Female
45	Treatment
45	Parkinson's disease
45	Middle Aged
41	Aged
30	Adult
29	Levodopa
26	Parkinson Disease (drug therapy)
24	Animals
22	Antiparkinson agent
21	Dyskinesia
20	Parkinson Disease (genetics)
20	Chemotherapy
18	Subthalamic nucleus
18	Comparative study
17	D2 Dopamine receptor
16	Parkinson Disease (physiopathology)
16	Multiple system atrophy
16	Animal
15	Ropinirole
15	Mutation
15	Dopamine
15	Dopamine agonist
15	Aged, 80 and over
14	Europe
14	Agonist
12	Parkinsonism
12	Genetics
12	Basal ganglion
12	Antiparkinson Agents (adverse effects)
11	Parkinson Disease (therapy)
11	Deep brain stimulation
10	levodopa
10	Levodopa (adverse effects)
10	Genotype
10	Early
10	Double blind study
10	Disease Models, Animal
10	Antiparkinson Agents (therapeutic use)
9	rating scales
9	Severity of Illness Index
9	Safety
9	Review
9	Prognosis
9	Parkinson Disease (complications)
9	France
9	Exploration
9	Diagnosis
9	Corpus striatum
9	Animal model
8	Recommendation
8	Phenotype
8	Parkinson Disease (metabolism)
8	Monkey
8	Double-Blind Method
8	Disease Progression
8	Child
8	Adolescent
7	dyskinesia
7	Treatment Outcome
7	Rats
7	Levodopa (therapeutic use)
7	Gene
7	Follow-Up Studies
7	Dystonia
7	Dopamine (metabolism)
7	Degeneration
7	D3 Dopamine receptor
6	clinimetrics
6	Young Adult
6	Time Factors
6	Thalamus
6	Reproducibility of Results
6	Pramipexole
6	Pedigree
6	Parkinson Disease (etiology)
6	Parkinson Disease (diagnosis)
6	Encephalon
6	Emission tomography
6	Dopamine receptor
6	Differential diagnostic
6	Depression
6	Complication
6	Analysis of Variance
5	diagnosis
5	deep brain stimulation
5	Tremor
5	Toxicity
5	Supranuclear ophthalmoplegia
5	Risk Factors
5	Quality of Life
5	Psychotropic
5	Positron
5	Pathogenesis
5	Parkinson Disease (pathology)
5	Neurotoxin
5	Multicenter study
5	Mice
5	Medicine
5	Long term
5	Indoles (therapeutic use)
5	Experimental study
5	European
5	Electrical stimulus
5	Electric Stimulation Therapy
5	Elderly
5	Dyskinesia, Drug-Induced (etiology)
5	Dementia
5	Cross-Sectional Studies
5	Corpus Striatum (metabolism)
5	Cohort Studies
5	Brain (vertebrata)
5	Brain (physiopathology)
5	Body movement
5	Advanced stage
5	Activities of Daily Living
4	treatment
4	subthalamic nucleus
4	multiple system atrophy
4	depression
4	dementia
4	Symptomatology
4	Surveys and Questionnaires
4	Speech
4	Sleep disorder
4	Rats, Sprague-Dawley
4	Rat
4	Putamen
4	Psychometrics
4	Protein Kinases (metabolism)
4	Prospective Studies
4	Progressive
4	Positron-Emission Tomography
4	Polymorphism, Single Nucleotide
4	Piribedil
4	Pharmacokinetics
4	Pathophysiology
4	Pathology
4	Parkinson’s disease
4	Parkinson
4	Parkinson Disease (psychology)
4	Parkinson Disease (history)
4	Parkinson Disease (diagnostic imaging)
4	Oxidopamine
4	Neuropsychological Tests
4	Mutation (genetics)
4	Mouse
4	Motor control
4	Longitudinal Studies
4	Locus niger
4	Lewy body
4	Levodopa (pharmacology)
4	Iron
4	Instrumentation therapy
4	Instrumental stimulation
4	Indoles (adverse effects)
4	Genetic determinism
4	Genetic Predisposition to Disease
4	Force
4	Fluctuations
4	Family study
4	Evolution
4	Evaluation scale
4	Etiopathogenesis
4	Drug Therapy, Combination
4	Dopamine Agents (therapeutic use)
4	Degenerative disease
4	Corpus Striatum (drug effects)
4	Clinical trial
4	Clinical management
4	Case-Control Studies
4	Antiparkinson Agents (pharmacology)
4	Antiparkinson Agents (administration & dosage)
4	Alleles
3	subthalamic nucleus stimulation
3	piribedil
3	dystonia
3	dopamine
3	dopamine agonist
3	disability
3	Validity
3	Ubiquitin-Protein Ligases (genetics)
3	Synchronization
3	Surgery
3	Supranuclear Palsy, Progressive (diagnosis)
3	Subthalamic Nucleus (physiopathology)
3	Subthalamic Nucleus (physiology)
3	Serotonin
3	Reliability
3	Release
3	Rasagiline
3	Questionnaire
3	Public health
3	Psychiatric Status Rating Scales
3	Protein Kinases (genetics)
3	Progressive supranuclear palsy
3	Primates
3	Prevention
3	Positron emission tomography
3	Polymorphism, Genetic
3	Polymerase chain reaction
3	Point Mutation
3	Placebo
3	Performance evaluation
3	Parkinson Disease, Secondary (metabolism)
3	Parkinson Disease, Secondary (etiology)
3	Parkinson Disease (mortality)
3	Parkinson Disease (epidemiology)
3	Pallidum
3	Neuroprotective agent
3	Neuroprotective Agents (therapeutic use)
3	Neurology
3	Nerve Tissue Proteins (genetics)
3	Nerve Net (physiopathology)
3	Multiple System Atrophy (diagnosis)
3	Mitochondria (metabolism)
3	Macaca mulatta
3	Macaca fascicularis
3	Huntington disease
3	History, 19th Century
3	High frequency
3	Heterozygote
3	Handicap
3	Genetic Predisposition to Disease (genetics)
3	Genetic Linkage
3	Genetic Association Studies
3	Functional Laterality
3	Follow up study
3	Family Health
3	Experimental disease
3	Executive function
3	Enzyme inhibitor
3	Electrophysiology
3	Electromyography
3	Electrodes, Implanted
3	Electric
3	Dyskinesia, Drug-Induced (physiopathology)
3	Dyskinesia, Drug-Induced (drug therapy)
3	Dose-Response Relationship, Drug
3	Disability
3	Corpus Striatum (physiopathology)
3	Confidence Intervals
3	Computational Biology
3	Cognitive disorder
3	Carrier Proteins (genetics)
3	Callithrix jacchus
3	Brain (pathology)
3	Brain (metabolism)
3	Brain (diagnostic imaging)
3	Biological activity
3	Basal Ganglia (physiopathology)
3	Autoradiography
3	Association
3	Anatomic pathology
3	Amino Acid Substitution
3	Acute
3	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology)
2	validity
2	validation
2	substantia nigra
2	response regulator
2	reliability
2	psychometrics
2	pramipexole
2	pollen flow
2	perampanel
2	parkinsonism
2	neuroprotection
2	neurodegeneration
2	motor fluctuations
2	motor complications
2	monotherapy
2	methods: statistical
2	livestock breeds
2	hypothalamus
2	haemochromatosis
2	guideline
2	grazing
2	executive functions
2	diagnostic criteria
2	developmental toxicology terminology
2	developmental toxicology nomenclature
2	developmental toxicology glossary
2	development
2	biodiversity
2	basal ganglia
2	apomorphine
2	Validation
2	United Kingdom
2	Ubiquitin-Protein Ligases (metabolism)
2	UPDRS
2	UPDRS = Unified Parkinson's Disease Rating Scale
2	Tyrosine 3-Monooxygenase (metabolism)
2	Translational Medical Research (methods)
2	Thalamic Nuclei (physiopathology)
2	Survival
2	Supranuclear Palsy, Progressive (drug therapy)
2	Statistics, Nonparametric
2	Sporadic
2	Species Specificity
2	Sensitivity and Specificity
2	Schizophrenia
2	Rotigotine
2	Risk factor
2	Revision
2	Registries
2	Randomization
2	Radiopharmaceuticals
2	RNA, Messenger (metabolism)
2	PubMed (statistics & numerical data)
2	Psychomotor Performance (physiology)
2	Psychomotor Performance (drug effects)
2	Psychiatry
2	Proteins
2	Proteins (genetics)
2	Protein-Serine-Threonine Kinases (genetics)
2	Protein Precursors (metabolism)
2	Posture
2	Postural hypotension
2	Postoperative
2	Population
2	Piperidines (therapeutic use)
2	Perampanel
2	Parkinsonian Disorders (pathology)
2	Parkinsonian Disorders (metabolism)
2	Parkinsonian Disorders (genetics)
2	Parkinsonian Disorders (drug therapy)
2	Parkinson Disease (surgery)
2	Parkinson Disease (enzymology)
2	Parents (psychology)
2	Paintings (history)
2	Oxidopamine (toxicity)
2	Outcome Assessment (Health Care)
2	Oral administration
2	Onset time
2	Observer Variation
2	Nootropic agent
2	Newborn
2	Neurotoxins (toxicity)
2	Neurons (pathology)
2	Neurodegenerative Diseases (genetics)
2	NMDA receptor
2	NF1
2	Myelodysplastic syndrome
2	Mutation, Missense
2	Mutation, Missense (genetics)
2	Multivariate Analysis
2	Movement (physiology)
2	Motor system disorder
2	Molecular Sequence Data
2	Models
2	Models, Neurological
2	Mitochondria (physiology)
2	Mitochondria (drug effects)
2	Mice, Inbred C57BL
2	Metamemory
2	Memory retrieval
2	Membrane Glycoproteins (genetics)
2	Medicine in Art
2	Magnetic Resonance Imaging (methods)
2	Macaca
2	L‐dopa
2	Lod Score
2	Locomotion
2	Lipids
2	Limbic system
2	Ligands
2	Lewy body disease
2	Lewy body dementia
2	Levodopa (administration & dosage)
2	Levetiracetam
2	Lesion
2	International Cooperation
2	Innervation
2	Inflammation
2	Indoles (pharmacokinetics)
2	Incidence
2	Image Processing, Computer-Assisted
2	Image Processing, Computer-Assisted (methods)
2	Homozygosity
2	Haplotype
2	HH, hereditary haemochromatosis
2	HEK293 Cells
2	Glutamate receptor
2	Germany
2	Genome-Wide Association Study
2	Genetic mapping
2	Genetic linkage
2	Genetic Vectors (adverse effects)
2	Genetic Variation
2	Genetic Variation (genetics)
2	Genetic Loci
2	Gene-Environment Interaction
2	Gene Frequency
2	Gene Expression Regulation
2	GTP Cyclohydrolase (genetics)
2	Functional imaging
2	Functional Laterality (physiology)
2	Frontotemporal dementia
2	Frontotemporal Lobar Degeneration (genetics)
2	Frontal cortex
2	Friedreich Ataxia (genetics)
2	Friedreich Ataxia (epidemiology)
2	Fluorodeoxyglucose F18
2	Ferritin
2	Familial disease
2	Exons (genetics)
2	Exome
2	Evaluation
2	Europe (epidemiology)
2	Eukaryotic Initiation Factor-4G (genetics)
2	Essential
2	Ergot derivatives
2	Epidemiology
2	Entacapone
2	Enkephalins (metabolism)
2	Dysphagia
2	Dyskinesias (etiology)
2	Dyskinesia, Drug-Induced (prevention & control)
2	Dyskinesia, Drug-Induced (metabolism)
2	Dysfunction
2	Dysarthria
2	Drug
2	Drug combination
2	Drug Combinations
2	Dose activity relation
2	Dopaminergic pathway
2	Dopaminergic neuron
2	Dopamine Agonists (therapeutic use)
2	Dopamine Agonists (pharmacology)
2	Dopamine Agonists (adverse effects)
2	Dopamine Agents (pharmacology)
2	Dopamine Agents (adverse effects)
2	Dopa
2	Deep Brain Stimulation
2	Deep Brain Stimulation (methods)
2	Data Curation
2	DNA Mutational Analysis
2	D1 Dopamine receptor
2	Cytochrome P450
2	Critical study
2	Conserved Sequence
2	Consensus conference
2	Cognitive control
2	Cognition
2	Clinical Trials as Topic
2	Classification
2	Chronic
2	Chorea
2	Child, Preschool
2	Cerebrovascular disease
2	Cerebral cortex
2	Cerebral Palsy (psychology)
2	Central nervous system
2	Cells, Cultured
2	Catecholamine
2	Catechol O-methyltransferase
2	Case study
2	Carrier protein
2	Calcium (metabolism)
2	Cabergoline
2	Bromocriptine
2	Brassica napus
2	Brain Mapping
2	Blood
2	Base Sequence
2	Apolipoproteins E (genetics)
2	Antiparkinson Agents (pharmacokinetics)
2	Aminoacid
2	Alzheimer's disease
2	Alzheimer disease
2	Alzheimer Disease (genetics)
2	Algorithms
2	Age of onset
2	Age of Onset
2	Accuracy
2	Abnormal movement
2	AMPA receptor
2	AMPA receptor antagonist
2	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
1	“anti‐HBc alone”
1	δ-Toxin
1	β2M, β2-microglobulin
1	zona incerta
1	xanthophyll cycle
1	working memory
1	wireless phones
1	whole‐genome analysis
1	well‐being
1	wearing‐off
1	wall-rock peridotite
1	volar pads
1	visceral abnormality
1	visceral abnormalities
1	vigilance

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/corpus/ParkinsonFrance.storage/ParkinsonFranceV1/Data/UK/Analysis/KwdEn.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK) Index « Mots-clés originaux en anglais » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)Index « Mots-clés originaux en anglais » - tête de navigation

Index : Keywords

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Mots-clés originaux en anglais » - tête de navigation